Catalyst Wire Dossier Catalyst Wire Dossier

Alogliptin benzoate and pioglitazone hydrochloride

Alogliptin benzoate and pioglitazone hydrochloride · Padagis Israel Pharmaceuticals Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alogliptin benzoate and pioglitazone hydrochloride, covering 2015-08-28 to 2015-08-28. Get the full timeline:

Most recent: FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

See pricing